We are live on ! Find out more
OXFD

Oxford Immunotec Global PLC Ordinary Shares
OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Oxford Immunotec Global PLC Ordinary Shares in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 60 → 0 (-60)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $400M → $0 (-$400M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 60

Holders
–
Holders Change
-60
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
60
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
FLAM
First Light Asset Management
Minnesota
-$86.4M
2
PCH
Polar Capital Holdings
United Kingdom
-$44.9M
3
ECM
Endurant Capital Management
California
-$39.1M
4
GPGA
Grandeur Peak Global Advisors
Utah
-$33.8M
5
SM
Senvest Management
New York
-$25.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
FLAM
1
First Light Asset Management
Minnesota
– -$86.4M -4,946,629 Closed
PCH
2
Polar Capital Holdings
United Kingdom
– -$44.9M -2,568,385 Closed
ECM
3
Endurant Capital Management
California
– -$39.1M -2,240,421 Closed
GPGA
4
Grandeur Peak Global Advisors
Utah
– -$33.8M -1,933,955 Closed
SM
5
Senvest Management
New York
– -$25.7M -1,470,593 Closed
Alyeska Investment Group
6
Alyeska Investment Group
Illinois
– -$23.4M -1,341,518 Closed
Millennium Management
7
Millennium Management
New York
– -$18.4M -1,056,349 Closed
DM
8
Deerfield Management
New York
– -$18.3M -1,049,035 Closed
BG
9
Bellevue Group
Switzerland
– -$14M -800,157 Closed
Renaissance Technologies
10
Renaissance Technologies
New York
– -$8.94M -511,700 Closed
SAM
11
Silvercrest Asset Management
New York
– -$8.16M -467,001 Closed
PCM
12
Penn Capital Management
Pennsylvania
– -$7.99M -457,674 Closed
New York State Common Retirement Fund
13
New York State Common Retirement Fund
New York
– -$6.09M -348,965 Closed
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
– -$5.82M -333,437 Closed
EP
15
Eversept Partners
New York
– -$5.37M -307,742 Closed
TAM
16
Tocqueville Asset Management
New York
– -$4.85M -277,450 Closed
GFI
17
Global Frontier Investments
South Carolina
– -$5.89M -272,281 Closed
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
– -$4.23M -242,448 Closed
Neuberger Berman Group
19
Neuberger Berman Group
New York
– -$3.09M -177,000 Closed
BC
20
Birchview Capital
Vermont
– -$2.97M -170,303 Closed
Two Sigma Advisers
21
Two Sigma Advisers
New York
– -$2.84M -162,600 Closed
Two Sigma Investments
22
Two Sigma Investments
New York
– -$2.71M -155,433 Closed
Citadel Advisors
23
Citadel Advisors
Florida
– -$2.6M -148,841 Closed
HWM
24
HighMark Wealth Management
Minnesota
– -$2.18M -124,966 Closed
KCM
25
Kornitzer Capital Management
Kansas
– -$1.98M -113,400 Closed
1
2 3

OXFD Hedge Fund Activity: Q1 2021 in Review

0 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q1 2021, worth a combined $0 — down 100% from $400M a quarter earlier.

Sellers outnumbered buyers: 60 funds closed out of OXFD and 0 opened new positions — a net loss of 60 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was First Light Asset Management, exiting entirely with an estimated $86.4M sold.

  • 0 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q1 2021, down from 60 in Q4 2020.
  • Funds reported $0 of Oxford Immunotec Global PLC Ordinary Shares stock for Q1 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q1 2021 and 60 closed out, a net change of -60 holders.
  • The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q1 2021 was First Light Asset Management, an estimated $86.4M sold.

Based on aggregated 13F filings for Q1 2021.